日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

抗体和 CAR 介导的巨噬细胞毒性的可利用机制

Liu Tianyi, Zhang Meng, Farsh Tatyanah, Li Haolong, Kishishita Audrey, Barpanda Abhilash, Leung Stanley G, Zhu Jun, Jung Hyuncheol, Hua Junjie Tony, Zhu Xiaolin, Kim Alexander B, Goo Young Ah, Son Minsoo, Kim Jaenyeon, Subramanian Aish, Sjöström Martin, Fuh Katherine C, Chapman Jocelyn S, Carnevale Julia, Gilbert Luke A, Lakkaraju Aparna, Bruno Peter M, Quigley David, Wiita Arun P, Feng Felix Y, DeSelm Carl J

The genomics revolution comes to the immunopeptidome

基因组学革命席卷免疫肽组学领域

Bruno, Peter M

A multi-subunit autophagic capture complex facilitates degradation of ER stalled MHC-I in pancreatic cancer

多亚基自噬捕获复合物促进胰腺癌中内质网滞留的MHC-I的降解

Berquez, Marine; Li, Alexander L; Luy, Matthew A; Venida, Anthony C; O'Loughlin, Thomas; Rademaker, Gilles; Barpanda, Abhilash; Hu, Jingjie; Yano, Julian; Wiita, Arun; Gilbert, Luke A; Bruno, Peter M; Perera, Rushika M

The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning.

化疗药物 CX-5461 的主要细胞毒性机制是拓扑异构酶 II 中毒

Bruno Peter M, Lu Mengrou, Dennis Kady A, Inam Haider, Moore Connor J, Sheehe John, Elledge Stephen J, Hemann Michael T, Pritchard Justin R

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

一种Pt(IV)前药优先靶向吲哚胺-2,3-双加氧酶,可增强卵巢癌免疫化疗疗效。

Awuah, Samuel G; Zheng, Yao-Rong; Bruno, Peter M; Hemann, Michael T; Lippard, Stephen J

Predicting cancer drug mechanisms of action using molecular network signatures

利用分子网络特征预测抗癌药物的作用机制

Pritchard, Justin R; Bruno, Peter M; Hemann, Michael T; Lauffenburger, Douglas A